Melatonin in cardiovascular disease
- 23 August 2012
- journal article
- Published by Taylor & Francis Ltd in Expert Opinion on Investigational Drugs
- Vol. 21 (11), 1593-1596
- https://doi.org/10.1517/13543784.2012.716037
Abstract
This editorial refers to “Cardiovascular effects of melatonin receptor agonists”. The hormone melatonin is synthesized primarily in the pineal gland, retina, several peripheral tissues and organs. In the circulation, the concentration of melatonin follows a circadian rhythm, with high levels at night providing timing cues to target tissues endowed with melatonin receptors. Based on the data available, the last 18 years indicate that melatonin influences multiple factors of the cardiovascular function. Multiple evidences reveal that the rhythmicity of melatonin has a crucial role in a variety of cardiovascular pathophysiological processes including anti-inflammatory, antioxidant, anti-hypertensive and possibly as an antilipidemic function. Melatonin receptors receive and transduce melatonin's message to influence daily and seasonal rhythms of physiology. The melatonin message is translated through the interaction between the melatonin receptors (MT1 and MT2) and its coupling to G proteins, which are potent...This publication has 16 references indexed in Scilit:
- Melatonina y enfermedad cardiovascular: ¿mito o realidad?Revista Española de Cardiología (English Edition), 2012
- The role of melatonin in acute myocardial infarctionFrontiers in Bioscience-Landmark, 2012
- Melatonin as a natural ally against oxidative stress: a physicochemical examinationJournal of Pineal Research, 2011
- Clinical Aspects of Melatonin in the Acute Coronary SyndromeCurrent Vascular Pharmacology, 2009
- Basic Mechanisms of Oxidative Stress and Reactive Oxygen Species in Cardiovascular InjuryTrends in Cardiovascular Medicine, 2007
- Role of Oxidative Stress in Cardiac Hypertrophy and RemodelingHypertension, 2007
- Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive RatsThe Journal of pharmacology and experimental therapeutics, 2007
- Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemiareperfusion: role of cardiolipinThe FASEB Journal, 2006
- Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive ratsAmerican Journal of Physiology-Renal Physiology, 2003
- The global burden of disease, 1990–2020Nature Medicine, 1998